NASDAQ$ISPR

Ispire Technology Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Ispire's financial performance increased in Q2 2024, marked by revenue growth and strategic initiatives.

Ispire Technology Inc. reported a 30% increase in revenue to $41.7 million for the fiscal second quarter ended December 31, 2023. The growth was primarily driven by a 149% increase in North American cannabis vaping hardware sales. The company is focusing on expanding its market presence and strategic initiatives.

  • Total revenue increased by 30% to $41.7 million compared to the same period last year.
  • North American cannabis vaping hardware sales increased by 149% year over year, reaching $19.5 million.
  • Gross profit increased by 24.1% to $6.4 million.
  • The company is pursuing ISO and GMP certification for its Malaysian facility and Pre-market Tobacco Product Application approval in the U.S.

Headline financials

Total Revenue

$41.7M

Previous: $61.2M-31.8%
EPS (adj)

-$0.07

Previous: -$0.06-16.7%
Capital Expenditures

-$1.13M

No prior period
Free Cash Flow

-$5.15M

No prior period
Net Income

-$4.02M

Previous: $128K-3252.3%
Operating Income

-$3.95M

Previous: $226K-1846.5%
Gross Profit

$6.38M

Previous: $8.51M-25.1%
Stock-Based Comp

$1.88M

No prior period

Revenue & EPS history

Ispire · Revenue · Quarterly

$41.7M

Q2 2024-31.8%vs Q2 2023
Beat estimate in 2 of 11 quarters(18%)
ActualEstimate

Revenue by segment

Ispire · $20.1M total across 1 segment · Q4 2025

  • Vaping Products
    $20.1M

Forward guidance

Ispire projects revenue for cannabis vaping products to be in the range of $80 million to $90 million, representing growth of 100% to 125% from fiscal year 2023. Revenue for tobacco vaping products for fiscal year 2024 is projected to be in the range of $95 million to $105 million, representing growth in the range of 33% to 47% from fiscal year 2023.

Tailwinds

  • Revenue for cannabis vaping products for fiscal year 2024 is projected to be in the range of $80 million to $90 million.
  • Expected cannabis vaping products revenue represents growth of 100% to 125% from fiscal year 2023.
  • Revenue for tobacco vaping products for fiscal year 2024 is projected to be in the range of $95 million to $105 million.
  • Expected tobacco vaping products revenue represents growth in the range of 33% to 47% from fiscal year 2023.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.2%

Avg return

Earnings day

+0.3%

Avg return

5 days after

-9.1%

Avg return

30 days after

31%

5 / 16 earnings

Positive

+27.2%

Q1 2024

Best reaction

-12.7%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-5.7%+1.2%+1.2%
Q2 2026+9.5%+14.4%-20.9%
Q1 2026-9.0%-11.0%+26.4%
Q4 2025-1.8%-19.0%-28.9%
Q3 2025-3.7%+6.6%-9.5%
Q2 2025-8.4%-6.6%-14.6%
Q1 2025-4.0%+4.2%-2.6%
Q4 2024+13.4%+7.6%+6.7%
Q3 2024+5.9%+20.2%+18.6%
Q2 2024-12.7%-16.7%-32.4%
Q1 2024+27.2%+2.1%-19.9%
Q4 2023+7.7%+6.0%+0.7%
Q1 2023-9.9%+0.5%-15.6%
Q4 2022-3.9%-1.7%-18.2%
Q3 2023-3.9%-1.7%-18.2%
Q3 2022-3.9%-1.7%-18.2%
Q2 2023
Q2 2021
Q1 2022

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro